Studies
| Study Title: | Understanding Adaptation in Multiple Sclerosis: The Role of Cognitive Change, Personality, and Acceptance |
| Rationale: | Multiple sclerosis (MS) is a chronic neurological condition that affects cognitive, emotional, and psychological functioning. While physical symptoms of MS are well documented, less is known about how individuals psychologically adapt to living with the condition over time. This study examines cognitive change, personality traits, coping patterns, and acceptance as factors related to resilience and emotional well being among adults living with MS in Canada. The goal is to better understand the psychological processes that support adaptation. |
| Study Description: |
This research is a non commercial, academic Honours Psychology thesis conducted at Capilano University under faculty supervision and full Research Ethics Board approval (REB Protocol 2025-036-CAPS-ESKANDARI AND SCHIMANSKI; Approved February 9, 2026; Expiry February 9, 2027).
The study uses a confidential online survey hosted on Capilano University’s licensed Qualtrics platform, with secure Canadian data storage.
Participants will:
Participation takes approximately 15–25 minutes. You may access the online survey here: https://capilanopsych.qualtrics.com/jfe/form/SV_cMxMVTyn1QuppAy No identifying information such as names, IP addresses, or contact details is collected. All data are confidential and analyzed in aggregate. Quotations, if used, will be fully de identified. The findings will be presented as part of an Honours Psychology thesis and may be shared at academic conferences or in future peer reviewed publications. |
| Starting Date: | 2026-03-01 |
| Ending Date: | 2026-06-30 |
| Who can participate: | Individuals who:
|
| Trial Institution: | Capilano University, North Vancouver, British Columbia, Canada |
| Trial Investigator: | Sepideh Eskandari Principal Investigator Honours Psychology
Student Supervisor: Dr. Lesley Schimanski, PhD Faculty, Department of Psychology Capilano University |
| Contact Information: | Sepideh Eskandari, sepideheskandari@my.capilanou.ca |
| Trial Funding: | This study does not receive external grant funding. This research is an undergraduate Honours thesis that is institutionally supported and academically sponsored by Capilano University through faculty supervision and Research Ethics Board oversight. The study is non-commercial and not affiliated with pharmaceutical or biotechnology companies. |
